Abstract
Abstract
Purpose
In continuous manufacturing of pharmaceuticals, dry granulation is of interest because of its large throughput capacity and energy efficiency. In order to manufacture solid oral dosage forms continuously, valid control strategies for critical quality attributes should be established. To this date, there are no published control strategies for granule size distribution in continuous dry granulation.
Methods
In-line laser diffraction was used to determine the size of granules in a continuous roll compaction/dry granulation line (QbCon® dry). Different process parameters were evaluated regarding their influences on granule size. The identified critical process parameters were then incorporated into control strategies. The uncontrolled and the controlled processes were compared based on the resulting granule size. In both processes, a process parameter was changed to induce a shift in median particle size and the controller had to counteract this shift.
Results
In principle, all process parameters that affect the median particle size could also be used to control the particle size in a dry granulation process. The sieve impeller speed was found to be well suited to control the median particle size as it reacts fast and can be controlled independently of the throughput or material.
Conclusion
The median particle size in continuous roll compaction can be controlled by adjusting process parameters depending on real-time granule size measurements. The method has to be validated and explored further to identify critical requirements to the material and environmental conditions.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference48 articles.
1. Lee SL, O'Connor TF, Yang XC, Cruz CN, Chatterjee S, Madurawe RD, et al. Modernizing pharmaceutical manufacturing: from batch to continuous production. J Pharm Innov. 2015;10(3):191–9. https://doi.org/10.1007/s12247-015-9215-8.
2. Lee SL. Current FDA perspective for continuous manufacturing [conference presentation]. MIT-CMAC 2nd International Symposium on Continuous Manufacturing of Pharmaceuticals, September 26–27, 2016; Cambridge, MA, USA2016.
3. Plumb K. Continuous processing in the pharmaceutical industry - changing the mind set. Chemical Engineering Research & Design. 2005;83(A6):730–8. https://doi.org/10.1205/cherd.04359.
4. Rantanen J, Khinast J. The future of pharmaceutical manufacturing sciences. J Pharm Sci. 2015;104(11):3612–38. https://doi.org/10.1002/jps.24594.
5. Lee SL. Quality Considerations for Continuous Manufacturing Guidance for Industry. Food and Drug Administration. 2019. https://www.fda.gov/media/121314/download. Accessed 03.08.2020 08:27.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献